Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Српски
  • Yкраї́нська
  • Log In
    Have you forgotten your password?
Repository logoRepository logo
  • Communities & Collections
  • All Contents
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Српски
  • Yкраї́нська
  • Log In
    Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Ozsahin, DU"

Now showing 1 - 4 of 4
Results Per Page
Sort Options
  • No Thumbnail Available
    Item
    Comparative Evaluation of the Treatment of COVID-19 with Multicriteria Decision-Making Techniques
    Yildirim, FS; Sayan, M; Sanlidag, T; Uzun, B; Ozsahin, DU; Ozsahin, I
    Objectives. The outbreak of coronavirus disease 2019 (COVID-19) was first reported in December 2019. Until now, many drugs and methods have been used in the treatment of the disease. However, no effective treatment option has been found and only case-based successes have been achieved so far. This study aims to evaluate COVID-19 treatment options using multicriteria decision-making (MCDM) techniques. Methods. In this study, we evaluated the available COVID-19 treatment options by MCDM techniques, namely, fuzzy PROMETHEE and VIKOR. These techniques are based on the evaluation and comparison of complex and multiple criteria to evaluate the most appropriate alternative. We evaluated current treatment options including favipiravir (FPV), lopinavir/ritonavir, hydroxychloroquine, interleukin-1 blocker, intravenous immunoglobulin (IVIG), and plasma exchange. The criteria used for the analysis include side effects, method of administration of the drug, cost, turnover of plasma, level of fever, age, pregnancy, and kidney function. Results. The results showed that plasma exchange was the most preferred alternative, followed by FPV and IVIG, while hydroxychloroquine was the least favorable one. New alternatives could be considered once they are available, and weights could be assigned based on the opinions of the decision-makers (physicians/clinicians). The treatment methods that we evaluated with MCDM methods will be beneficial for both healthcare users and to rapidly end the global pandemic. The proposed method is applicable for analyzing the alternatives to the selection problem with quantitative and qualitative data. In addition, it allows the decision-maker to define the problem simply under uncertainty. Conclusions. Fuzzy PROMETHEE and VIKOR techniques are applied in aiding decision-makers in choosing the right treatment technique for the management of COVID-19.
  • No Thumbnail Available
    Item
    Capacity Evaluation of Diagnostic Tests For COVID-19 Using Multicriteria Decision-Making Techniques
    Sayan, M; Yildirim, FS; Sanlidag, T; Uzun, B; Ozsahin, DU; Ozsahin, I
    In December 2019, cases of pneumonia were detected in Wuhan, China, which were caused by the highly contagious coronavirus. This study is aimed at comparing the confusion regarding the selection of effective diagnostic methods to make a mutual comparison among existing SARS-CoV-2 diagnostic tests and at determining the most effective one. Based on available published evidence and clinical practice, diagnostic tests of coronavirus disease (COVID-19) were evaluated by multi-criteria decision-making (MCDM) methods, namely, fuzzy preference ranking organization method for enrichment evaluation (fuzzy PROMETHEE) and fuzzy technique for order of preference by similarity to ideal solution (fuzzy TOPSIS). Computerized tomography of chest (chest CT), the detection of viral nucleic acid by polymerase chain reaction, cell culture, CoV-19 antigen detection, CoV-19 antibody IgM, CoV-19 antibody IgG, and chest X-ray were evaluated by linguistic fuzzy scale to compare among the diagnostic tests. This scale consists of selected parameters that possessed different weights which were determined by the experts' opinions of the field. The results of our study with both proposed MCDM methods indicated that the most effective diagnosis method of COVID-19 was chest CT. It is interesting to note that the methods that are consistently used in the diagnosis of viral diseases were ranked in second place for the diagnosis of COVID-19. However, each country should use appropriate diagnostic solutions according to its own resources. Our findings also show which diagnostic systems can be used in combination.
  • No Thumbnail Available
    Item
    Efficacy Evaluation of Antiretroviral Drug Combinations for HIV-1 Treatment by Using the Fuzzy PROMETHEE
    Sayan, M; Ozsahin, DU; Sanlidag, T; Sultanoglu, N; Yildirim, FS; Uzun, B
    The Human Immunodeficiency Virus (HIV) causes disease by damaging the immune system. If treatment is not initiated, the immune system collapses and this leads to Acquired Immune Deficiency Syndrome (AIDS). The drugs used in the treatment of HIV infection slow or stop the damage caused by the virus to the immune system. In this study, we analyzed the treatment options of HIV since there are many antiretroviral drug combinations available for the treatment and each combination has different properties. The variety of different combinations can cause confusion for physicians in practice. Based on this aim, we proposed the fuzzy PROMETHEE technique, a multi-criteria decision making technique based on mutual comparison of the options. The most common antiretroviral drug combinations used in the HIV treatment were evaluated and compared corresponding to their parameters by the PROMETHEE technique. According to our results, integrase-based inhibitor drug combinations were predominantly preferred. BIC + TAF/FTC (bictegravir + tenofoviralafenamide/emtricitabine) outranked the other antiretroviral drug combinations with a net flow of 0.0437, followed by DTG + ABC/3TC (dolutegravir + abacavir/lamivudine) then DTG + TAF/FTC (dolutegravir + tenofoviralafenamide/emtricitabine). The results obtained with the application of decision-making theories on these option treatment methods will provide significant information for relevant patients, HIV treatment specialists and drug-makers.
  • No Thumbnail Available
    Item
    Evaluating the Efficacy of Adult HIV Post Exposure Prophylaxis Regimens in Relation to Transmission Risk Factors by Multi Criteria Decision Method
    Sayan, M; Sanlidag, T; Sultanoglu, N; Uzun, B; Yildirim, FS; Ozsahin, DU
    There are approximately 39 million people living with the human immunodeficiency virus (HIV) worldwide. Although antiretroviral treatment (ART) has revolutionized the treatment and management of the HIV infection, a cure still remains elusive. In addition to ART's success at prolonging the lives of the infected individuals, it also has its uses in other cases. For example, post exposure prophylaxis (PEP) ART regimens are used after potential exposure to HIV to prevent the establishment of the HIV infection by up to 80% when administered in a timely manner. There are many guidelines available for these situations; however, they have differences in terms of their content and very few guidelines suggest specific PEP ART regimens for particular risk factors. Our study uses a multi criteria decision making method called Fuzzy PROMETHEE to evaluate the effectiveness of selected PEP ART regimens according to specified transmission risk factors for HIV. The risk factors were the criteria in this study and were weighted according to experts' opinions in terms of their relative importance.

Manisa Celal Bayar University copyright © 2002-2025 LYRASIS

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback